35 related articles for article (PubMed ID: 3433806)
1. Single- and multiple-dose pharmacokinetics of nufenoxole in healthy human subjects.
Brownsill RD; Hiley MP; Vose CW; Steiner JA; Stafford JE; McAllister A; Rose DA; Gerry N
Xenobiotica; 1987 Nov; 17(11):1373-7. PubMed ID: 3433806
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of clofazimine in healthy volunteers.
Schaad-Lanyi Z; Dieterle W; Dubois JP; Theobald W; Vischer W
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):9-15. PubMed ID: 3559339
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
Kuhnz W; Schütt B; Power J; Back DJ
Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and pharmacokinetics of nufenoxole in animals and humans: an example of stereospecific hydroxylation of an isoquinuclidine ring.
Cook CS; Campion JG; Hribar JD; Karim A
Xenobiotica; 1990 Oct; 20(10):1065-80. PubMed ID: 2082596
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects.
Dieterle W; Mann J; Kutz K
J Clin Pharmacol; 2004 Jan; 44(1):59-66. PubMed ID: 14681342
[TBL] [Abstract][Full Text] [Related]
13. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
J Clin Pharmacol; 2007 Jan; 47(1):56-63. PubMed ID: 17192502
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cinnarizine after single and multiple dosing in healthy volunteers.
Castañeda-Hernández G; Vargas-Alvarado Y; Aguirre F; Flores-Murrieta FJ
Arzneimittelforschung; 1993 May; 43(5):539-42. PubMed ID: 8328998
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence evaluation of two different oral formulations of loperamide (Diarex Lactab vs Imodium capsules).
Doser K; Meyer B; Nitsche V; Binkert-Graber P
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):431-6. PubMed ID: 8556221
[TBL] [Abstract][Full Text] [Related]
16. Dependence liability of two antidiarrheals, nufenoxole and loperamide.
Korey A; Zilm DH; Sellers EM
Clin Pharmacol Ther; 1980 May; 27(5):659-64. PubMed ID: 7371363
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics of fluorazole].
Firsov AA; Kandenatsii IB; Glezer MG; Agapitova IV; Dombrovskiĭ VS
Antibiot Khimioter; 1995 Sep; 40(9):42-6. PubMed ID: 8651830
[TBL] [Abstract][Full Text] [Related]
18. Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole.
Kamali F; Huang ML
Br J Clin Pharmacol; 1996 Feb; 41(2):125-8. PubMed ID: 8838438
[TBL] [Abstract][Full Text] [Related]
19. Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.
Moriarty KJ; Rolston DD; Kelly MJ; Shield M; Clark ML
Gut; 1985 Jan; 26(1):75-80. PubMed ID: 2578119
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
